Philip Siberg
Chief Government Officer
Good morning. Pleasure to be right here. I am right here to current Senzime This autumn 2025 outcomes in addition to a short abstract of the 12 months of 2025. So if we begin by total 2025, it was a 12 months of continued accelerated development, and we took clear continued steps in direction of profitability.
We grew about 90% in fixed currencies. So we met the steerage of reaching above SEK 110 million in fixed currencies. Our underlying gross margin elevated. Our OpEx remained secure and our adjusted EBITDA improved by about 16%.
So the basics are there. We’re actually reconfirming our objective to achieve constructive money circulation throughout 2026, and that is going to be fueled by continued development and stringent price management.
So this was a abstract. I am going to dig down deeper into the numbers. If we take a look at This autumn alone, it was a robust ending to the 12 months. We greater than doubled the enterprise. We reached SEK 28.3 million in reported revenues and SEK 31.2 million in case you’re wanting on the fixed currencies.
The expansion was pushed by extra essential hospital wins, very sturdy sensor development. We had extra tips coming in that I am going to dig deeper into, and we had an thrilling regulatory approval in Japan that began kicking off the subsequent gen.
And it was additionally 1 / 4 of launching further new merchandise. We got here out with the EMGINE software program suite that I’ll speak somewhat bit extra about. So in case you take a look at our put in base of TetraGraphs and the shipments we’re doing, it retains on rising.
All year long, we shipped out 2,139 TetraGraphs, predominantly the next-gen TetraGraph comparable to only beneath 900
